FOLFIRI plus panitumumab in the treatment of wild-type KRAS and wild-type NRAS metastatic colorectal cancer
Abstract Background The aim of this study was to investigate the efficacy and safety of first-line panitumumab plus folinic acid, 5-fluorouracil and irinotecan (FOLFIRI) in patients with wild-type KRAS and wild-type NRAS metastatic colorectal cancer (mCRC). Methods Patients with wild-type KRAS and w...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMC
2018-03-01
|
| Sarja: | World Journal of Surgical Oncology |
| Aiheet: | |
| Linkit: | http://link.springer.com/article/10.1186/s12957-018-1359-9 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|